Terns Pharmaceuticals Inc (TERN) support and resistance · $6.12B cap
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
This page maps Terns Pharmaceuticals Inc (TERN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
TERN currently screens at market cap $6.12B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TERN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TERN quote page for the session range and the stock page for the full model.
Not investment advice.